DOVATO

This brand name is authorized in Austria, Australia, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, United Kingdom, United States

Active ingredients

The drug DOVATO contains a combination of these active pharmaceutical ingredients (APIs):

1 Lamivudine UNII 2T8Q726O95 - LAMIVUDINE

Lamivudine is a nucleoside analogue which has activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Its main mode of action is as a chain terminator of viral reverse transcription. Read about Lamivudine

2 Dolutegravir UNII 1Q1V9V5WYQ - DOLUTEGRAVIR SODIUM

Dolutegravir inhibits HIV integrase by binding to the integrase active site and blocking the strand transfer step of retroviral Deoxyribonucleic acid (DNA) integration which is essential for the HIV replication cycle. Read about Dolutegravir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DOVATO Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AR25	Lamivudine and dolutegravir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AR Antivirals for treatment of HIV infections, combinations
Discover more medicines within J05AR25

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11843H
Country: CA	Health Products and Food Branch	Identifier(s): 02491753
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 6188-MEE-0421
Country: EE	Ravimiamet	Identifier(s): 1799073, 1799084
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1191370001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 423096
Country: FR	Base de données publique des médicaments	Identifier(s): 67301231
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 374819
Country: HK	Department of Health Drug Office	Identifier(s): 66511
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8505
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250119F1029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1088256, 1088257
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 198692
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 21442
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100420992
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66226001
Country: US	FDA, National Drug Code	Identifier(s): 49702-246